To hear about similar clinical trials, please enter your email below
Trial Title:
Orthopedic Oncology Surgery: Navigation, Intraoperative Imaging and Virtual Reality
NCT ID:
NCT05918536
Condition:
Neoplasms
Muscle Neoplasm
Conditions: Official terms:
Neoplasms
Muscle Neoplasms
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Diagnostic Test
Intervention name:
evaluate the quality of surgical margins achievable with the use of navigated Intraoperative CT
Description:
Noninterventional, prospective study of patients operated on for musculoskeletal
neoplasms designed to evaluate the quality of surgical margins achievable with the use of
navigated Intraoperative CT
Arm group label:
Popolation
Summary:
Noninterventional, prospective study of patients operated on for musculoskeletal
neoplasms designed to evaluate the quality of surgical margins achievable with the use of
navigated Intraoperative CT
Criteria for eligibility:
Study pop:
Patients with primary and secondary cancers of the musculoskeletal system with estimated
survival greater than one year who are candidates for bone resection surgery or wide
excision of soft tissue lesion and/or radio and chemotherapy treatments
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Age: no limit
- Patients with musculoskeletal neoplasms predominantly in complex sites
- Patients who will have to undergo surgical resection/amputation for the management
of their clinical case
- Preparation of preoperative planning discussed at DMT
- Surgery performed with the aid of Intraoperative CT Navigated
- Written informed consent
Exclusion Criteria:
- Inability to perform pre-post treatment assessment
Gender:
All
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
"Regina Elena" National Cancer Institute
Address:
City:
Rome
Zip:
00144
Country:
Italy
Status:
Recruiting
Contact:
Last name:
Roberto Biagini, MD
Phone:
ND
Email:
roberto.biagini@ifo.it
Start date:
May 17, 2022
Completion date:
November 17, 2025
Lead sponsor:
Agency:
Regina Elena Cancer Institute
Agency class:
Other
Collaborator:
Agency:
Azienda Policlinico Umberto I
Agency class:
Other
Collaborator:
Agency:
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Agency class:
Other
Source:
Regina Elena Cancer Institute
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05918536
